No Pharma Money
En Español

Drugs Don’t Work If People Can’t Afford Them

Our vision is simple

Every person in the United States can get the prescription drugs they need at prices they can afford.

For too long, drug companies have shaped the system in their favor while patients pay the price.

We empower and mobilize patients and allies, hold accountable those in power, and fight to shape and achieve system-changing policies that make prescription drugs affordable for all. We are independent, bipartisan, and do not accept contributions from any organization that profits from the development or distribution of prescription drugs.

Learn More
Current Campaign · The ETHIC Act

Take action now

Help build support for the bipartisan ETHIC Act, which would help bring lower-cost generic medicines to patients sooner.

Write Your Representative
Jackie Trapp, a multiple myeloma patient from Muskego, Wisconsin

“My out-of-pocket drug costs for my multiple myeloma treatment could be as much as $21,000 a year. My energy to fight my cancer was diverted to finding ways to pay for my prescriptions.”

Jackie Trapp Muskego, Wisconsin

Millions of Americans struggle to afford the medications they need. We organize patients to change the policies that keep prices high.

Add Your Voice Share Your Story The most powerful advocates are the people living with the consequences of high prices every day. Your experience can help drive the fight for lower drug prices. Share Your Story
Our Impact

When patients organize, change happens

$2,000

Since 2025, for the first time, there's an annual cap on Medicare prescription drug costs

$35
Monthly insulin cap

Patients on Medicare pay no more than $35 a month for insulin since 2023.

1st
Drug price negotiation

The first negotiated prices under Medicare took effect in 2026.

$0
Free recommended vaccines

Recommended vaccines are free for patients on Medicare since 2023.

Stay Updated

News & Reports

All News
Latest News Nov 16, 2026

P4ADNow CEO to Urge Congress To Advance Bipartisan Reforms Targeting Big Pharma’s Patent Abuse During Testimony Before Senate Judiciary Committee

Merith Basey will bring patients’ stories to Capitol Hill as lawmakers examine how pharmaceutical companies block competition and keep drug prices high.  WASHINGTON, D.C. — Tomorrow, Patients For Affordable Drugs Now CEO Merith Basey will testify before the Senate Judiciary Committee at its hearing, “Prescribing Sunshine: How Competition & Transparency Lowers Prescription Drug Costs.” Basey […]

Read Article
Latest News Nov 13, 2026

The Week in Review in Prescription Drug Pricing: P4AD CEO to Testify at Senate Judiciary Hearing, ETHIC Momentum Grows, and more

Our CEO Merith Basey will testify at Tuesday’s Senate Judiciary Committee hearing, “Prescribing Sunshine: How Competition & Transparency Lowers Prescription Drug Costs.” The hearing will focus on legislation to address the pharmaceutical industry’s abuse of the patent system — including through patent thickets, pay-for-delay deals, product hopping, and abuse of the citizen petition process.

Read Article
Latest News Nov 6, 2026

The Week in Review in Prescription Drug Pricing: Negotiation Final Rule, CVS Breaks Up, and Keytruda Biosimilar Troubles

CMS published the final rule for the Medicare Drug Price Negotiation program, codifying the program and effectively closed a loophole that pharmaceutical manufacturers could exploit to delay negotiation, as we highlighted in our comments.

Read Article

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.